Drugs News and Research

RSS

Researchers exploit cancer cells' appetite for iron to treat tough tumors

Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account for about one in four cancer deaths.

9 Mar 2022

U.S. health care systems reduce costs, improve patient experience by delivering integrative care

U.S. health care systems and clinics report reducing costs, improving patient experience and health, while enhancing clinician wellbeing by delivering integrative care, according to a new white paper published by The Family Medicine Education Consortium and Samueli Foundation.

9 Mar 2022

IPD pooled analysis quantifies the underlying hematological response following malaria infection

A new malaria study using a very large analysis of pooled individual patient data (IPD) from more than 70,000 patients of all ages, has been published today in BMC Medicine.

9 Mar 2022

Increasing trend of antimicrobial resistance in Eastern Mediterranean Region of World Health Organization

Researchers investigated the rising antimicrobial resistance in the Eastern Mediterranean Region of the World Health Organization from 2017 to 2019.

9 Mar 2022

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

A new study provides an overview of the use of mathematical modeling to determine severe acute respiratory syndrome coronavirus 2 kinetics.

9 Mar 2022

Mushroom-derived compounds have potential for use as COVID-19 therapeutic

Researchers conducted virtual screening and validation of molecules derived from mushrooms for their activity against the main protease SARS-CoV-2.

9 Mar 2022

Assessment of oligonucleotides as COVID-19 treatment

A recent study posted to the bioRxiv* pre-print server assessed the ability of oligonucleotides in preventing the development of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions.

8 Mar 2022

Young people who stop using drugs can have high levels of life success in adulthood

Young people who stop using cannabis or amphetamines before becoming adults experience life success at the same levels of those who have never used drugs, according to a University of Queensland study.

8 Mar 2022

New analysis method to identify interacting proteins in a protein degrader-dependent manner

Protein degraders, which induce the protein degradation of target proteins, are expected to be the "next-generation drugs" because they can remove disease-related proteins from cells.

8 Mar 2022

UH researchers receive grant for developing new imaging technique to peer into ribosomes

Two University of Houston researchers are developing a type of spectroscopy to help understand how ribosomes make proteins deep within cells, the discovery of which could potentially guide drug design to treat cancers and viral infections.

8 Mar 2022

Illinois Tech receives $2.17 million NIH grant to develop drug treatments for cholera

Illinois Institute of Technology is receiving a four-year grant from the National Institutes of Health to fund research to develop drug treatments for cholera and other multi-drug-resistant strains of disease-causing bacteria.

8 Mar 2022

Researchers come one step closer to reversing the destructive aging process in egg cells

Throughout much of the world, increasing numbers of women are delaying having their first child until they are in their late thirties, and even into their forties.

8 Mar 2022

A promising approach for COVID-19 prophylaxis

SARS-CoV-2 viruses can hide from recognition by the immune system. However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections.

8 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

Current and future perspectives of mRNA technology

New research reports on the current and future perspectives on messenger ribonucleic acid technology, the platform on which the first successful COVID-19 vaccine was based.

8 Mar 2022

Study shows anti-itch and pain relief potential of protein in tick saliva

A protein found in tick saliva could be turned into a drug that eases itching and chronic pain in people.

8 Mar 2022

Glucocorticoid steroids improve muscle performance through distinct, sex-specific molecular pathways

Glucocorticoid steroids improved muscle performance through distinct, sex-specific molecular mechanisms in mice, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.

7 Mar 2022

Study offers insight into molecular biology of the brain in bipolar disorder patients

In a comprehensive study involving one of the largest-ever samples of post-mortem brains, scientists at the Lieber Institute for Brain Development, in collaboration with researchers at the Johns Hopkins School of Medicine and Bloomberg School of Public Health, have pinpointed significant differences in gene expression in two specific regions of the brains of hundreds of patients who had bipolar disorder.

7 Mar 2022

World's largest genetic study reveals fresh details about severe Covid-19

The world's largest study of the genetics of critical Covid-19, involving more than 57,000 people, has revealed fresh details about some of the biological mechanisms behind the severe form of the disease.

7 Mar 2022

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Researchers from Columbia Engineering, Fiocruz's Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases--enzymes that allow SARS-CoV-2 to reproduce--they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.

7 Mar 2022

Drugs News and Research

Researchers exploit cancer cells' appetite for iron to treat tough tumors

U.S. health care systems reduce costs, improve patient experience by delivering integrative care

IPD pooled analysis quantifies the underlying hematological response following malaria infection

Increasing trend of antimicrobial resistance in Eastern Mediterranean Region of World Health Organization

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

Mushroom-derived compounds have potential for use as COVID-19 therapeutic

Assessment of oligonucleotides as COVID-19 treatment

Young people who stop using drugs can have high levels of life success in adulthood

New analysis method to identify interacting proteins in a protein degrader-dependent manner

UH researchers receive grant for developing new imaging technique to peer into ribosomes

Illinois Tech receives $2.17 million NIH grant to develop drug treatments for cholera

Researchers come one step closer to reversing the destructive aging process in egg cells

A promising approach for COVID-19 prophylaxis

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Current and future perspectives of mRNA technology

Study shows anti-itch and pain relief potential of protein in tick saliva

Glucocorticoid steroids improve muscle performance through distinct, sex-specific molecular pathways

Study offers insight into molecular biology of the brain in bipolar disorder patients

World's largest genetic study reveals fresh details about severe Covid-19

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News